Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment)

• Ngā kaituhi matua: Nakamura T (Author), Kubota T (Author), Iwakaji A (Author), Imada M (Author), Kapás M (Author), Morio Y (Author)
• Hōputu: Pukapuka
• I whakaputaina: Dove Medical Press, 2016-01-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Tadakatsu Nakamura,1 Tomoko Kubota,1 Atsushi Iwakaji,1 Masayoshi Imada,1 Margit Kapás,2 Yasunori Morio1 1Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan; 2Developmental Drug Metabolism and Pharmacokinetics, Gedeon Richter Plc, Budapest, Hungary Purpose: Cari...